Lunit’s INSIGHT CXR software will be available on Philips’ X-ray solutions.
Medical artificial intelligence (AI) start-up Lunit announced, during the 2021 European Congress of Radiology (ECR) annual meeting, that its AI software will now be available on Philips Healthcare’s diagnostic X-ray solutions.
For additional ECR 2021 coverage, click here.
This move marks the latest extension of Philips’ AI portfolio in precision diagnosis. It is designed to improve patient outcomes and experience, according to a company statement.
Lunit INSIGHT CXR detects findings and provides abnormality score on a chest X-ray image
Credit: Lunit
Lunit INSIGHT CXR chest detection suite can identify 10 of the most common findings on chest X-rays by mapping finding locations and displaying a scored calculation of where those findings actually are. By using abnormality scores, the software prioritizes scans, allowing for faster triage of the most critical images.
Based on existing publications, including studies in Radiology and JAMA Network Open, the algorithm can perform with 97 percent to 99 percent accuracy.
This collaboration will potentially accelerate the diagnostic capabilities of facilities, said Daan van Manen, general manager for diagnostic X-ray at Philips.
“Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact,” Manen said. “Our partnership with Lunit to incorporate their diagnostic AI into our X-ray platform combines with a host of smart workflow features in the Philips Eleva user interface, our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow.”
Lunit INSIGHT CXR is already CE marked and clinically available in Europe, Middle East, Latin America, South East Asia, Australia, and New Zealand. The company expects U.S. Food & Drug Administration clearance this year.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter here.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.
Study Shows Benefits of AI in Detecting Lung Cancer Risk in Non-Smokers
November 22nd 2023Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.